Expressions of the CIP/KIP family of CDK inhibitor proteins in primary intestinal large B-cell lymphomas: Correlation with clinical outcomes

Pathology Research and Practice

Volumn 198, Issue 11, 2002, Pages 741-746

  Go, Jai H ^a  

^a Dankook University College of Medicine   (South Korea)

Author keywords

Intestine; Lymphoma; P21; P27; P57

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR; PARAFFIN; PROTEIN P21; PROTEIN P27; PROTEIN P53; PROTEIN P57;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER REGRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTESTINE LYMPHOMA; LARGE CELL LYMPHOMA; MALE; PROTEIN EXPRESSION; PROTEIN FAMILY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; TISSUE SECTION;

EID: 0036924894     PISSN: 03440338     EISSN: None     Source Type: Journal    
DOI: 10.1078/0344-0338-00330     Document Type: Article

References (26)

1. Chilosi M, Doglioni C, Magalini A, Inghirami G, Krampera M, Nadali G, Rahal D, Pedron S, Benedetti A, Scardoni M, Macri E, Lestani M, Menestrina F, Pizzolo G, Scarpa A (1996) p21/WAF1 cyclin-kinase inhibitor expression in non-Hodgkin's lymphomas: a potential marker of p53 tumor-suppressor gene function. Blood 88: 4012-4020
2. Erlanson M, Portin C, Linderholm B, Lindh J, Roos G, Landberg G (1998) Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood 92: 770-777
3. Ferreri AJ, Ponzoni M, Pruneri G, Freschi M, Rossi R, Dell'Oro S, Baldini L, Buffa R, Carboni N, Villa E, Viale G (2001) Immunoreactivity for p27(KIP1) and cyclin E is an independent predictor of survival in primary gastric non-Hodgkin's lymphoma. Int J Cancer 94: 599-604
4. Go JH (2001) Expression pattern of p27 protein in primary gastric lymphomas. Cancer Res Treat 33: 318-323 (In Korean)
5. Go JH, Yang WI (2001) Expressions of p53 and p21 in primary gastric lymphomas. J Korean Med Sci 16: 731-735
6. Go JH, Yang WI, Ree HJ (2002) CD10 expression in primary intestinal large B-cell lymphomas: Its clinical significance. Arch Pathol Lab Med 126: 956-960
7. Ito Y, Takeda T, Sakon M, Tsujimoto M, Monden M, Matsuura N (2001) Expression of p57/Kip2 protein in hepatocellular carcinoma. Oncology 61: 221-225
8. Ito Y, Takeda T, Wakasa K, Tsujimoto M, Matsuura N (2001) Expression of p57/Kip2 protein in pancreatic adenocarcinoma. Pancreas 23: 246-250
9. Jaffe ES, Harris NL, Stein H, and Vardiman JW eds. World Health Organization Classification of Tumors: Tumors of Hematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2001: 157-160
10. Kolar Z, Flavell JR, Ehrmann J, Rihakova P, Macak J, Lowe D, Crocker J, Vojtesek B, Young LS, Murray PG (2000) Apoptosis of malignant cells in Hodgkin's disease is related to expression of the cdk inhibitor p27KIP1. J Pathol 190: 604-612
11. Li X, Hui AM, Shi YZ, Takayama T, Makuuchi M (2001) Reduced p21(WAF1/CIP1) expression is an early event in gallbladder carcinogenesis and is of prognostic significance for patients with carcinomas of the gallbladder. Hum Pathol 32: 771-777
12. Li Y, Nagai H, Ohno T, Yuge M, Hatano S, Ito E, Mori N, Saito H, Kinoshita T (2002) Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood 100: 2572-2577
13. Maestro R, Gloghini A, Doglioni C, Piccinin S, Vukosavljevic T, Gasparotto D, Carbone A, Boiocchi M (1997) Human non-Hodgkin's lymphomas overexpress a wild-type form of p53 which is a functional transcriptional activator of the cyclin-dependent kinase inhibitor p21. Blood 89: 2523-2528
14. Marches R, Hsueh R, Uhr JW (1999) Cancer dormancy and cell signaling: induction of p21(waf1) initiated by membrane IgM engagement increases survival of B lymphoma cells. Proc Natl Acad Sci U S A 96: 8711-8715
15. Matsumoto M, Furihata M, Ohtsuki Y, Sasaguri S, Ogoshi S (2000) Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma. Anticancer Res 20: 1947-1952
16. Morgner A, Bayerdorffer E, Neubauer A, Stolte M (2000) Malignant tumors of the stomach. Gastric mucosa-associated lymphoid tissue lymphoma and Helicobacter pylori. Gastroenterol Clin North Am 29: 593-607
17. Morosetti R, Kawamata N, Gombart AF, Miller CW, Hatta Y, Hirama T, Said JW, Tomonaga M, Koeffler HP (1995) Alteration of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. Blood 86: 1924-1930
18. Nakamura M, Sakaki T, Hashimoto H, Nakase H, Ishida E, Shimada K, Konishi N (2001) Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas. Cancer Res 61: 6335-6339
19. Pajic A, Spitkovsky D, Christoph B, Kempkes B, Schuhmacher M, Staege MS, Brielmeier M, Ellwart J, Kohlhuber F, Bornkamm GW, Polack A, Eick D (2000) Cell cycle activation by c-myc in a burkitt lymphoma model cell line. Int J Cancer 87: 787-793
20. Palazzo JP (2001) Cyclin-dependent kinase inhibitors - a novel class of prognostic indicators. Hum Pathol 32: 769-770
21. Poluha W, Poluha DK, Chang B, Crosbie NE, Schnhoff CM, Kilpatrick DL, Ross AH (1996) The cyclin-dependent kinase inhibitor p21WAF1 is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16: 1335-1341
22. Rosenberg E, Demopoulos RI, Zeleniuch-Jacquotte A, Yee H, Sorich J, Speyer JL, Newcomb EW (2001) Expression of cell cycle regulators p57(KIP2), cyclin D1, and cyclin E in epithelial ovarian tumors and survival. Hum Pathol 32: 808-813
23. Sanchez-Beato M, Saez AI, Martinez-Montero JC, Sol Mateo M, Sanchez-Verde L, Villuendas R, Troncone G, Piris MA (1997) Cyclin-dependent kinase inhibitor p27KIP1 in lymphoid tissue: p27KIP1 expression is inversely proportional to the proliferative index. Am J Pathol 151: 151-160
24. Sanchez-Beato M, Saez AI, Navas IC, Algara P, Sol Mateo M, Villuendas R, Camacho F, Sanchez-Aguilera A, Sanchez E, Piris MA (2001) Overall survival in aggressive B-cell lymphomas is dependent on the accumulation of alterations in p53, p16, and p27. Am J Pathol 159: 205-213
25. Stefanaki K, Tzardi M, Kouvidou CH, Chaniotis V, Bolioti M, Vlychou M, Zois M, Kakolyris S, Delides G, Rontogianni D, Georgoulias V, Kanavaros P (1998) Expression of p53, p21, mdm2, Rb, bax and Ki67 proteins in lymphomas of the mucosa-associated lymphoid tissue (MALT). Anticancer Res 18: 2403-2408
26. Worm J, Bartkova J, Kirkin AF, Straten P, Zeuthen J, Bartek J, Guldberg P (2000) Aberrant p27Kip1 promoter methylation in malignant melanoma. Oncogene 19: 5111-5115